This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Lilly Diabetes Joins The American Diabetes Association As A National Sponsor Of The 2013 Tour De Cure® Cycling Event

Stocks in this article: LLY

INDIANAPOLIS, Nov. 27, 2012 /PRNewswire/ -- Today Lilly Diabetes announced it has joined the American Diabetes Association (Association) as a national sponsor of the 2013 Tour de Cure, the Association's annual nationwide cycling event that attracts more than 60,000 riders across 44 states. 

Lilly Diabetes has been an active supporter of the Association's efforts to Stop Diabetes® through support of key organizational initiatives including Living with Type 2 Diabetes, Everyday Wisdom™ kits, Safe at School® and diabetes camps. For more than 10 years Lilly Diabetes has been one of the largest supporters of diabetes summer camps in the U.S.

"Lilly Diabetes supports the Tour de Cure because at its heart, this event is a celebration of health, hope and community," said Enrique Conterno, president, Lilly Diabetes. "It also helps connect our employees with one another, and importantly, to connect them with the diabetes community we are dedicated to serving."

The Tour de Cure is one of the Association's signature fundraising events in which the organization's Stop Diabetes movement comes to life, encouraging participants to: Share, Act, Learn and Give. The Tour asks riders and donors to start a chain reaction by supporting its year-long series of cycling events across the country. Riders with type 1 or type 2 diabetes, as well as those who support them, can participate in courses of varying distances regardless of skill level. In 2013, Lilly Diabetes employees will participate as local and national team riders and will host local events and company-wide fundraising activities. The Lilly Foundation will match individual employee donations of $25 or more. In 2011, more than $18 million was raised to support the mission of the American Diabetes Association: to prevent and cure diabetes and to improve the lives of all people affected by diabetes.  

"Lilly Diabetes has truly been passionate in supporting the American Diabetes Association's mission and becoming part of our movement to Stop Diabetes," said Larry Hausner, CEO, American Diabetes Association. "We are excited to be working together again to help raise critical funds for diabetes through our Tour de Cure events nationwide."

Diabetes affects nearly 26 million children and adults in the United States – 8.3 percent of the U.S. population. It is estimated that an additional 79 million have prediabetes, putting them at risk for developing type 2 diabetes. Diabetes can lead to blindness, heart disease, stroke, kidney failure and amputations. Some common symptoms/signs of diabetes are extreme thirst, frequent urination, blurry vision, and tingling in the feet.

To register to ride, visit

About Lilly Diabetes Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions–from medicines to support programs and more–to make lives better. For more information, visit

About Eli Lilly and Company Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers—through medicines and information—for some of the world's most urgent medical needs. Information about Lilly is available at

HI80116 11/2012 PRINTED IN USA ©Lilly USA, LLC 2012. All rights reserved.


1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,090.33 +8.45 0.41%
NASDAQ 4,810.3630 +36.8910 0.77%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs